Skip to content
Picoplatin
Picoplatin is a small molecule pharmaceutical. It is currently being investigated in clinical studies.
Download report
Favorite
Commercial
Therapeutic Areas
No data
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
No data
Labels
FDA
EMA
No data
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
No data
HCPCS
No data
Clinical
Clinical Trials
8 clinical trials
View more details
Mock data
Subscribe for the real data
Indications Phases 4
No data
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Small cell lung carcinomaD055752—11——2
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Colorectal neoplasmsD01517921———2
Lung neoplasmsD008175C34.9011———2
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
NeoplasmsD009369C802————2
LymphomaD008223C85.91————1
Prostatic neoplasmsD011471C611————1
Breast neoplasmsD001943EFO_0003869C501————1
Ovarian neoplasmsD010051EFO_0003893C561————1
Pancreatic neoplasmsD010190EFO_0003860C251————1
Head and neck neoplasmsD0062581————1
Gastrointestinal neoplasmsD005770C26.91————1
Urinary bladder neoplasmsD001749C671————1
Indications Without Phase
No data
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common namePICOPLATIN
INNpicoplatin
Description
Picoplatin is a platinum-based antineoplastic agent in clinical development by Poniard Pharmaceuticals (previously NeoRx) for the treatment of patients with solid tumors.
Classification
Small molecule
Drug classantineoplastics (platinum derivatives)
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)
Cc1ccccn1.Cl[Pt]Cl.N
Identifiers
PDB—
CAS-ID181630-15-9
RxCUI—
ChEMBL IDCHEMBL3544907
ChEBI ID—
PubChem CID6918325
DrugBankDB04874
UNII IDB5TAN0L720 (ChemIDplus, GSRS)
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Additional graphs summarizing 178 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
0 adverse events reported
View more details